PMID: 9548192Apr 21, 1998Paper

FDG uptake, tumour characteristics and response to therapy: a review

Nuclear Medicine Communications
T A Smith

Abstract

The use of FDG-PET imaging in tumour detection is now well established. Many studies have suggested that changes in the uptake of FDG predict tumour response to therapy and that further clinical information regarding tumour grade and proliferative status may also be derived from FDG-uptake scans. More studies are required to verify the role of FDG-PET in patient management. Upregulation of hexokinase and glucose transporters, especially Glut-1, and downregulation of glucose-6-phosphatase are frequently associated with transformation. The extent of these changes has been related to both differentiation and proliferation largely corresponding with FDG-uptake studies.

Citations

Feb 3, 2000·Annals of Nuclear Medicine·R D Finn
Nov 2, 2004·Der Radiologe·M WeckesserO Schober
Jul 20, 2006·Skeletal Radiology·Tatsuya YoshidaMasazumi Tsuneyoshi
Sep 30, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Stephanie GuillermetDaniel Fagret
Oct 4, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Manuel Rodríguez-Garrido, Cristina Asensio-del-Barrio
Sep 6, 2005·Amino Acids·R Bergmann, J Pietzsch
Sep 28, 2007·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Joseph A Thie
Mar 28, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Ching-yee Oliver WongConrad Nagle
May 14, 2005·International Journal of Radiation Oncology, Biology, Physics·Andrei PugachevJohn L Humm
Dec 10, 1999·Clinics in Chest Medicine·J J Erasmus, E F Patz
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Robert S MalyapaPerry W Grigsby
Dec 31, 2002·International Journal of Radiation Oncology, Biology, Physics·Sasa MuticDaniel A Low
Dec 31, 2002·International Journal of Radiation Oncology, Biology, Physics·Christophe Van de WieleRudi Andre Dierckx
Aug 1, 2000·Clinical Privilege White Paper
Oct 22, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A R Padhani
Nov 28, 2002·Nuclear Medicine and Biology·Qi-Huang ZhengGary D Hutchins
Jun 7, 2003·Critical Reviews in Oncology/hematology·Tarik BelhocinePierre Rigo
Feb 24, 2001·Joint, Bone, Spine : Revue Du Rhumatisme·C Le Rest, Y Bizais
Sep 8, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N Houssami, C M Costelloe
Nov 18, 2000·Clinical Nuclear Medicine·M CharronD W Townsend
Jun 21, 2006·Applied Immunohistochemistry & Molecular Morphology : AIMM·Amanda Ashton-SagerAlaa M Afify
Nov 11, 2010·Fiziologiia cheloveka·V D Son'kinE B Akimov
Aug 19, 2008·World Journal of Surgical Oncology·Akio SakamotoKen Arai
Jan 21, 2006·AJR. American Journal of Roentgenology·Osama MawlawiMarvin Chasen
Mar 18, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Vibhu KapoorFrank S Torok
Feb 7, 2008·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Eric L RosenDavid A Mankoff
Mar 29, 2001·The British Journal of Radiology·A R Padhani, J E Husband
May 30, 2001·Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T·P G. KluetzD W. Townsend
Jan 15, 2005·Cancer Biotherapy & Radiopharmaceuticals·Mei TianKeigo Endo
Jun 27, 2014·Pharmaceuticals·Markus Mitterhauser, Wolfgang Wadsak
Mar 10, 2015·International Journal of Molecular Sciences·Justus WeberWalter Mier
Nov 21, 2007·Cancer Investigation·Jeffrey A NemethRobert A Beckman
Mar 31, 2016·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Kyoungjune PakIn Joo Kim
Jul 13, 2012·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Hiroyuki Kato, Masanobu Nakajima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2022 Meta ULC. All rights reserved